
Sumatriptan Nasal Spray for Acute Migraine
Abstract
The efficacy and side effects of intranasal sumatriptan (20 mg, 10 mg) or placebo in the treatment of a single migraine attack were evaluated in two randomized, double-blind, multicenter studies of 409 and 436 adult patients, funded by Glaxo Wellcome.
DOI: https://doi.org/10.15844/pedneurbriefs-11-12-11 | Journal eISSN: 2166-6482
Language: English
Page range: 95 - 95
Published on: Dec 1, 1997
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 1997 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.